LU72162A1 - - Google Patents
Info
- Publication number
- LU72162A1 LU72162A1 LU72162A LU72162A LU72162A1 LU 72162 A1 LU72162 A1 LU 72162A1 LU 72162 A LU72162 A LU 72162A LU 72162 A LU72162 A LU 72162A LU 72162 A1 LU72162 A1 LU 72162A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2415740A DE2415740C2 (de) | 1974-04-01 | 1974-04-01 | Verwendung von Orotsäure bei der analgetischen Behandlung mit Dextropropoxyphen, Natriumsalicylat oder Metamizol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU72162A1 true LU72162A1 (xx) | 1976-08-19 |
Family
ID=5911830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU72162A LU72162A1 (xx) | 1974-04-01 | 1975-03-28 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4061741A (xx) |
| AT (1) | AT361630B (xx) |
| BE (1) | BE827318A (xx) |
| CA (1) | CA1054051A (xx) |
| DE (1) | DE2415740C2 (xx) |
| ES (1) | ES436179A1 (xx) |
| FR (1) | FR2265407B1 (xx) |
| GB (1) | GB1497826A (xx) |
| LU (1) | LU72162A1 (xx) |
| NL (1) | NL7503857A (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321918A (en) * | 1979-10-23 | 1982-03-30 | Clark Ii William T | Process for suppressing immunity to transplants |
| FR2694196B1 (fr) * | 1992-07-30 | 1994-10-21 | Rochade | Composition médicinale utilisable comme agent antiviral. |
| WO2001024803A2 (en) * | 1999-10-04 | 2001-04-12 | John Carter | Pharmaceutical compositions containing copper, salicylic acid and vitamines c |
| US8034823B2 (en) * | 2005-02-22 | 2011-10-11 | Savvipharm Inc | Method of increasing drug oral bioavailability and compositions of less toxic orotate salts |
| RU2594155C2 (ru) * | 2009-09-04 | 2016-08-10 | Тэктикал Терапеутикс, Инк | Новые композиции и способы получения 5-амино- или замещенных амино-1,2,3-триазолов и триазол-оротатных композиций |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE108537C (xx) * | ||||
| GB923608A (xx) * | 1960-03-11 | 1963-04-18 | ||
| DE1155880B (de) * | 1961-03-17 | 1963-10-17 | Curt H Schwietzer Dr Dr | Verfahren zur Herstellung von konzentrierten, waessrigen Orotsaeure-Loesungen |
| DE1240224B (de) * | 1962-08-10 | 1967-05-11 | Merck Ag E | Verfahren zum Stabilisieren von Orotsaeure in saurer, waessriger oder waessrig-alkoholischer, insbesondere vitaminhaltiger Loesung |
| DE1617631B1 (de) * | 1966-12-31 | 1971-12-23 | Merz & Co | Verwendung von Orotsäure und bzw. oder deren physiologisch unbedenklichen anorganischen oder organischen Salzen in Hautpflegemitteln |
| DE2131946A1 (de) * | 1971-06-26 | 1972-12-28 | Storto Martin Dipl Chem Dr | Salze der Orotsaeure mit Aminoalkoholen sowie Verfahren zu deren Herstellung und Anwendung |
| DE2247538C2 (de) * | 1972-09-28 | 1975-03-06 | Servomed Arznei Gmbh, 1000 Berlin | Antitussivum |
| JPS4955813A (xx) * | 1972-10-07 | 1974-05-30 |
-
1974
- 1974-04-01 DE DE2415740A patent/DE2415740C2/de not_active Expired
-
1975
- 1975-03-27 GB GB12931/75A patent/GB1497826A/en not_active Expired
- 1975-03-27 US US05/562,736 patent/US4061741A/en not_active Expired - Lifetime
- 1975-03-27 CA CA223,364A patent/CA1054051A/en not_active Expired
- 1975-03-28 LU LU72162A patent/LU72162A1/xx unknown
- 1975-03-28 FR FR7509881A patent/FR2265407B1/fr not_active Expired
- 1975-03-28 BE BE154884A patent/BE827318A/xx not_active IP Right Cessation
- 1975-03-28 AT AT240775A patent/AT361630B/de not_active IP Right Cessation
- 1975-04-01 NL NL7503857A patent/NL7503857A/xx not_active Application Discontinuation
- 1975-04-01 ES ES436179A patent/ES436179A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1054051A (en) | 1979-05-08 |
| ATA240775A (de) | 1980-08-15 |
| FR2265407A1 (xx) | 1975-10-24 |
| US4061741A (en) | 1977-12-06 |
| GB1497826A (en) | 1978-01-12 |
| DE2415740C2 (de) | 1983-12-01 |
| AT361630B (de) | 1981-03-25 |
| DE2415740A1 (de) | 1975-10-02 |
| BE827318A (fr) | 1975-09-29 |
| NL7503857A (nl) | 1975-10-03 |
| FR2265407B1 (xx) | 1978-08-04 |
| ES436179A1 (es) | 1977-02-01 |